Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Short Versus Long-term Levetiracetam in Brain Tumors: A Phase 3 Randomized Controlled Trial (LIBRA)

NCT06442748 is registered in ClinicalTrials.gov with Tata Memorial Centre as lead sponsor.

NCT NCT06442748
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06442748 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Short Versus Long-term Levetiracetam in Brain Tumors: A Phase 3 Randomized Controlled Trial (LIBRA)
Lead sponsor
Tata Memorial Centre
Phase
Phase 3
Overall status
Recruiting
Start date
July 4, 2024
Completion date
June 1, 2031
Enrollment
604 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

antiepileptics, brain tumors, levetiracetam, seizures